Skip to main content
. Author manuscript; available in PMC: 2022 May 9.
Published in final edited form as: Eur Urol. 2018 Oct 6;75(1):176–183. doi: 10.1016/j.eururo.2018.09.009

Table 4 –

Multivariable Cox regression analysis predicting clinical recurrence after SLND in 654 patients treated for nodal recurrence of prostate cancer

Predictor HR 95% CI p value
Gleason grade group
 ≤4 1.00 Ref.   –
 5 2.04 1.66–2.50 <0.0001
Time from RP to PSA rising, per 6 mo 0.98 0.96–0.99   0.025
HT administration at the time of PET/CT scan
 No 1.00 Ref.   –
 Yes 1.47 1.19–1.82   0.0005
Retroperitoneum involvement at PET/CT scan
 No 1.00 Ref.   –
 Yes 1.24 1.01–1.52   0.038
Positive spots at PET/CT scan
 ≤2 1.00 Ref.   –
 ≥3 1.26 1.05–1.61   0.019
PSA at SLND, ng/ml 1.05 1.04–1.07 <0.0001

CI = confidence interval; HR = hazard ratio; HT = hormonal therapy; PET/CT = positron emission tomography/computed tomography; PSA = prostate-specific antigen; Ref. = reference; RP = radical prostatectomy; SLND = salvage lymph node dissection.